SCHEMBL14957286

SCHEMBL14957286

CC(C)n1cc(C=O)c2cc(-c3ccccc3F)ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.44
ERN1 O75460 1/20 0.43
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 1/20 0.41
PTPRC P08575 1/20 0.40
PTPN1 P18031 1/20 0.40
ICMT O60725 1/20 0.40
TNKS O95271 1/20 0.40
TNKS2 Q9H2K2 1/20 0.40
MAP4K4 O95819 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MITF O75030 1/20 0.38
USP2 O75604 1/20 0.38
RAB9A P51151 1/20 0.38
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36
GRIA4 P48058 4/20 0.36
IMPDH2 P12268 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL670893 0.86 ALDH1A1 (0.42) PGRALDH1A1KDM4EMEN1KMT2A
SCHEMBL673549 0.84 SSTR5 (0.42) PGRALDH1A1KDM4EMEN1KMT2A
SCHEMBL14957974 0.82 KDM4E (0.43) PGRERN1ALDH1A1KDM4EMEN1
SCHEMBL671526 0.82 ALDH1A1 (0.51) PGRALDH1A1KDM4ETNKS2MEN1
SCHEMBL12182481 0.78 ALDH1A1 (0.65) ALDH1A1KDM4EPTPN1MEN1KMT2A
SCHEMBL670558 0.77 ALDH1A1 (0.43) ERN1ALDH1A1KDM4E
SCHEMBL14957551 0.75 MEN1 (0.37) PGRERN1ALDH1A1MEN1KMT2A
SCHEMBL1871346 0.75 ALDH1A1 (0.61) ALDH1A1KDM4EMEN1KMT2AMITF
SCHEMBL671605 0.73 PDE4B (0.46) ERN1ALDH1A1KDM4EPTPN1MEN1
SCHEMBL28587918 0.71 XDH (0.40) ALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2605658-B1 SPIROXAZOLIDINONE COMPOUNDS MERCK SHARP & DOHME (US) 2016-03-23 EP disclosed
US-8742110-B2 Spiroxazolidinone compounds MERCK SHARP & DOHME CORP. (US) 2014-06-03 US disclosed
US-20130131042-A1 SPIROXAZOLIDINONE COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2013-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131042-A1 SPIROXAZOLIDINONE COMPOUNDS SSTR5, SSTR2, SSTR4 PGR 466/4885ERN1 3500/4885ALDH1A1 1467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.